Strides Pharma may get transferred to a clutch of investors as promoters plan to exit
December 30, 2020
Company’s vaccine facility likely to go on stream in January
Strides Pharma Science Limited, with no successors to take the company forward, is at crossroads as promoters are planning to exit. With their plan to exit the company, it is learnt that the company may get transferred to a clutch of investors.
“The company is expected to be transferred to a clutch of investors as the promoters are looking to exit for personal reasons,” said a veteran pharma specialist, who did not want to be identified.